Kernel
Culver City, Los Angeles, California, United States
Publication-00
Citations-00
Conferences/Seminar-00
About Kernel
Kernel was founded in 2016 with the objective to improve the way we measure the brain. We evaluated every modality for measuring the brain to assess utility, scalability, ease-of-use, and technical readiness. In 2018, Kernel's team of world-class eng adiness. In 2018, Kernel's team of world-class engineers and scientists began developing a technology called time-domain functional near-infrared spectroscopy, which became our first hardware product - Kernel Flow. Flow allows for natural head motion, real-world measurements, and large scale data collection, while maintaining research-grade data quality. Kernel's AI and ML tools produce actionable biomarkers that take advantage of the volume of information-rich data that can quickly be gathered with Flow. We have built a software and services platform around our core hardware technology and are now on a mission to to accelerate treatment discovery, improve patient outcomes, and transform neuromedicine with precision biomarkers. Our system generates detailed maps of activity in the brain that provide a deep and scalable understanding of disease state and treatment response — the foundation on which the future of neuromedicine will be built. Flow2 is the most advanced non-invasive neuro measurement platform for translating research neuroimaging findings into clinical use. Enrolling by invitation in clinics across the West Coast for a biomarker study measuring various depression treatments. Recruiting healthy controls and MCI patients for a biomarker study measuring aging in adults over the age of 55. Kernel has demonstrated the ability to measure known functional changes in the brain in response to administering psychoactive substances. These results validate the biomarker capabilities of our system and demonstrate a key capability used in Phase I studies with our biopharma partners. Kernel Flow measures a biomarker for the acute effect of subanesthetic ketamine on the brain. Kernel Flow measures a biomarker that can distinguish cognitive impairment levels due to alcohol intoxication. ...view more